How should we treat mild and moderate-severe Crohn’s disease in 2017? A brief overview of available therapies Editorial Article uri icon

Overview

MeSH Major

  • Anti-Inflammatory Agents
  • Biological Products
  • Crohn Disease
  • Gastrointestinal Agents

publication date

  • February 2017

Research

keywords

  • Editorial

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1080/17474124.2017.1266935

PubMed ID

  • 27900879

Additional Document Info

start page

  • 95

end page

  • 97

volume

  • 11

number

  • 2